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confounders, as these individuals will have increased
acid output and may be more prone to gastro-
oesophageal reflux and less likely to acquire H pylori.w6
The trial by Harvey et al is indirect evidence that
using “test and treat” in patients with dyspepsia in pri-
mary care will not lead to an increase in symptoms of
gastro-oesophageal reflux disease.5 Other evidence to
support the effectiveness of the strategy comes from
randomised controlled trials comparing H pylori eradi-
cation versus placebo in H pylori positive patients.3
Whether small benefits in the order of 7% are
worthwhile depends on both the persistence of effects
of the treatment and its cost effectiveness. On the basis
of good data for up to two years of follow up, H pylori
eradication is likely to provide more lasting benefit
than acid suppression alone.1 Direct evidence of cost
effectiveness is awaited from an ongoing randomised
controlled trial funded by the Medical Research Coun-
cil that is comparing H pylori “test and treat” with acid
suppression in the initial management of dyspepsia in
more than 200 general practices in the United
Kingdom.
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Choice and equity: lessons from long term care
Government prefers greater equity of finance to equity of access
On the face of it, recent statements about theequation of choice with equity in the NHS andsocial care seem to strengthen the govern-
ment’s commitment to care services that are both fair
and responsive.1 Few would oppose increased choice for
consumers of public services as a general principle. The
United Kingdom,when judged overall, has long had one
of the most equitable healthcare systems among
developed countries. Inequalities in healthcare provision
and the health status of the population have, however,
always been marked,2 and improvement in equity has
always been an important policy objective.3 The govern-
ment is now arguing that patients should be given more
choice about how their own health care is managed and
that this managed choice will help to drive up quality in
the new, fixed price, internal market.4 This ideamay have
some attractions for patients who are unhappy with
aspects of their treatment and care, but we do know how
far choice will be realised in practice. Lessons from
recent history show that more educated, higher
socioeconomic groups tend to take advantage, patients
outside metropolitan areas find it hard to “shop around”
owing to lack of choice of hospitals, and in general
patients are unwilling to travel far anyway.5 6
In long term care provided by both NHS and local
authorities the mix of public and private finance
changes the terms of the debate about choice and
equity fundamentally. In their 1999 report on long
term care the majority of royal commissioners argued
for free personal care for all, but the government
decided that people on middle and higher incomes
should continue to pay for this care, a policy
recommended in a report by a minority of the
commissioners. The government argued that its
approach would be fairer, and in some ways it was
right. If payment for services is closely related to
individuals’ ability to pay for them then that is equitable
in terms of the financing of services. People on low
incomes in their own homes, with capital of no more
than £12 000 ($21 000; €18 000), are now paying a
smaller charge or no charge at all (a capital limit of
£19 500 applies to care homes). The difficulty comes
when one realises that equity of financing can conflict
with policies intended to increase equity of access or
provision.
Rather worryingly for the government, the level of
publicly financed provision has dropped, and the pro-
portion of older people receiving home help from
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social services continues to fall—down 40% since
1993.7 There has been a great deal of policy commen-
tary on this transfer of financial responsibility from the
state to older people in the lower to middle income
range, who may be struggling to afford to purchase
care and are often deterred by payments.8 9 Asking
people to pay for elements of their care assumes that
they will exercise choices in ways that maximise their
own wellbeing, largely uninfluenced by social and
other considerations, but this is often not the case.10
Such evidence begs the question: do we want a
system that offers greater equity of access to help
ensure that care needs are met, as the majority
commissioners argued? Or do we continue to leave
this to the market as the government decided for
those with means? There are different distributional
effects, for both finance and provision, in the two
positions. The minority commissioners and the
government argue that they have maintained a level of
private finance, to the tune of £1.1bn, from those
individuals with means so they can focus a publicly
funded safety net on those without. The main
counterargument, from the majority commissioners,
is that the current settlement seems to be unfair com-
pared with NHS policy—equal needs are clearly not
being treated equally11—and in our own research we
have found that 60% of the public believe this
situation to be unfair.12
So, in the ever more complicated policy jungle
boundaries between public and private finance and
provision of traditional welfare services are becoming
increasingly blurred. Within this blurring, though,
important trade offs are being made. The lesson from
long term care shows that New Labour tends to favour
greater equity of finance to equity of access when it is
given the choice
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A firm foundation for senior house officers
Foundation programme will provide a focused educational experience
Modernising Medical Careers highlightedchanges that will reform the senior houseofficer training grade in the United King-
dom.1 Implementing these long overdue reforms has
wide ranging implications for all training posts,2 3 as
outlined in the latest guidance on all training
programmes in The Next Steps.4 The main thrust is for
doctors to begin their careers with a two year founda-
tion programme. Thereafter they move on to specialist
training grades running through to consultant level.
This “run through” period would be shorter than the
current training period and competency based.
Introducing the foundation programme represents
a fundamental change for the senior house officer
grade. From August 2005 all medical graduates will
undertake an integrated planned programme of
general training. The first year will be similar to the
current preregistration year and will include full regis-
tration. The second year offers doctors further generic
skills training in a mixture of specialties. The end point
is to have competent doctors who are able to recognise
and manage acutely sick patients and are ready to
enter specialist training.
Many hospital departments currently rely on the
service commitment of 20 000 doctors in the senior
house officer grade. Some will be hard pressed to
release more service time of junior hospital doctors and
their supervisors to create time for education.
Thankfully, some helpful resources are available to
increase educational value in service, such as the
thoughtful Liberating Learning, which works along simi-
lar principles to the “one minute preceptor model.”5 6
Uncertainty surrounding the future contribution of
overseas doctors, who currently make up a sizeable
proportion of the senior house officer workforce, also
affects planning for service provision in hospitals and
at what point they enter training grades.
In order to enter the “run through” training grade,
senior house officers will now have to demonstrate to an
educational supervisor that they have achieved the
foundation programme competencies. These are similar
to those contained in the publication Good Medical Prac-
tice.7 They will have a record of in training assessment
(RITA) similar to that already in use in specialist training.
Among many challenges to achieve the goals of the
foundation programme are the practical issues in creat-
ing enough foundation year 1 posts for the foundation
year 2 posts and allowing space in foundation year 2 for
overseas doctors who already have registration.
Issues about the curriculum and competency frame-
work need addressing.What assessment methods will be
used to decide if a doctor has achieved the competency?
Who is best placed to make that assessment? It clearly
does not always have to be the consultant, but it does
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